115 related articles for article (PubMed ID: 32930120)
1. Identification of activated pathways in lung adenocarcinoma based on network strategy.
Yu B; Li T; Chen J; Wang FQ; Fu JH; Liu SM; Wang Y; Zhang X; Yang HT
J Cancer Res Ther; 2020; 16(4):793-799. PubMed ID: 32930120
[TBL] [Abstract][Full Text] [Related]
2. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
3. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
Dong S; Men W; Yang S; Xu S
Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
6. Lung adenocarcinoma pathology stages related gene identification.
Sun GZ; Zhao TW
Math Biosci Eng; 2019 Oct; 17(1):737-746. PubMed ID: 31731374
[No Abstract] [Full Text] [Related]
7. Construction of a transcription factor‑long non‑coding RNA‑microRNA network for the identification of key regulators in lung adenocarcinoma and lung squamous cell carcinoma.
Zhao S; Chen H; Ding B; Li J; Lv F; Han K; Zhou D; Yu B; Yu Y; Zhang W
Mol Med Rep; 2019 Feb; 19(2):1101-1109. PubMed ID: 30569133
[TBL] [Abstract][Full Text] [Related]
8. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.
Naruke T; Tsuchiya R; Kondo H; Asamura H
Ann Thorac Surg; 2001 Jun; 71(6):1759-64. PubMed ID: 11426744
[TBL] [Abstract][Full Text] [Related]
10. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
12. Possible pathways used to predict different stages of lung adenocarcinoma.
Chen X; Duan Q; Xuan Y; Sun Y; Wu R
Medicine (Baltimore); 2017 Apr; 96(17):e6736. PubMed ID: 28445293
[TBL] [Abstract][Full Text] [Related]
13. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
14. A novel network model identified a 13-gene lung cancer prognostic signature.
Guo NL; Wan YW; Bose S; Denvir J; Kashon ML; Andrew ME
Int J Comput Biol Drug Des; 2011; 4(1):19-39. PubMed ID: 21330692
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
[TBL] [Abstract][Full Text] [Related]
16. Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.
Dai C; Liu B; Li S; Hong Y; Si J; Xiong Y; Wu N; Ma Y
Technol Cancer Res Treat; 2021; 20():15330338211056809. PubMed ID: 34825849
[No Abstract] [Full Text] [Related]
17. Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma.
Tao Y; Li Y; Liang B
Future Oncol; 2020 Aug; 16(24):1825-1837. PubMed ID: 32501723
[No Abstract] [Full Text] [Related]
18. Comparison of dysregulated long noncoding RNAs in lung adenocarcinoma and spinal metastasis: A genome-wide analysis.
Wang H; Wang S; Liu P; Ma Y; Hu A; Sun C; Dong J
Neoplasma; 2019 Nov; 66(6):930-938. PubMed ID: 31390868
[TBL] [Abstract][Full Text] [Related]
19. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
[TBL] [Abstract][Full Text] [Related]
20. Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.
Tian W; Liu J; Pei B; Wang X; Guo Y; Yuan L
Oncol Rep; 2016 Apr; 35(4):2171-6. PubMed ID: 26781349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
